Impact of timing and combination of different BNT162b2 and ChAdOx1-S COVID-19 basic and booster vaccinations on humoral immunogenicity and reactogenicity in adults

[1]  Soon-young Park,et al.  Reactogenicity and Immunogenicity of the ChAdOx1 nCOV-19 Coronavirus Disease 2019 Vaccine in South Korean Healthcare Workers , 2022, Yonsei medical journal.

[2]  Dong Ho Kim,et al.  Immunogenicity and Durability of Antibody Responses to Homologous and Heterologous Vaccinations with BNT162b2 and ChAdOx1 Vaccines for COVID-19 , 2022, Vaccines.

[3]  Qian Wang,et al.  Antibody responses to Omicron BA.4/BA.5 bivalent mRNA vaccine booster shot , 2022, bioRxiv.

[4]  M. Proschan,et al.  Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses , 2022, Cell.

[5]  A. Rabaan,et al.  Update on the omicron sub‐variants BA.4 and BA.5 , 2022, Reviews in medical virology.

[6]  B. Charleston,et al.  Neutralizing antibody activity against 21 SARS-CoV-2 variants in older adults vaccinated with BNT162b2 , 2022, Nature Microbiology.

[7]  Huynh Ngoc Phuoc,et al.  Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine , 2022, Biomedicine & Pharmacotherapy.

[8]  L. Bekker,et al.  Effectiveness of BNT162b2 Vaccine against Omicron Variant in South Africa , 2021, The New England journal of medicine.

[9]  T. Gonen,et al.  Superior immunogenicity and effectiveness of the 3rd BNT162b2 vaccine dose , 2021, medRxiv.

[10]  A. Rodríguez-Morales,et al.  Heterologous prime–boost strategies for COVID-19 vaccines , 2021, Journal of Travel Medicine.

[11]  R. Najmanovich,et al.  Computational analysis of the effect of SARS-CoV-2 variant Omicron Spike protein mutations on dynamics, ACE2 binding and propensity for immune escape , 2021, bioRxiv.

[12]  H. Whitaker,et al.  Serological responses and vaccine effectiveness for extended COVID-19 vaccine schedules in England , 2021, Nature Communications.

[13]  R. Parker,et al.  Reduced Incidence of Long-COVID Symptoms Related to Administration of COVID-19 Vaccines Both Before COVID-19 Diagnosis and Up to 12 Weeks After , 2021, medRxiv.

[14]  Ishan Garg,et al.  COVID-19 Vaccine Booster: To Boost or Not to Boost , 2021, Infectious disease reports.

[15]  Michael I. Mandel,et al.  Waning Immunity after the BNT162b2 Vaccine in Israel , 2021, The New England journal of medicine.

[16]  A. Bollmann,et al.  Sex Differences in Clinical Course and Intensive Care Unit Admission in a National Cohort of Hospitalized Patients with COVID-19 , 2021, Journal of clinical medicine.

[17]  M. Hernán,et al.  Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study , 2021, The Lancet.

[18]  Dennis Andersson,et al.  Ensuring trust in COVID-19 data , 2021, Medicine.

[19]  David R. Holtgrave,et al.  New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021 , 2021, MMWR. Morbidity and mortality weekly report.

[20]  L. Abu-Raddad,et al.  Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar , 2021, medRxiv.

[21]  F. Huang,et al.  To mix or not to mix? A rapid systematic review of heterologous prime–boost covid-19 vaccination , 2021, Expert review of vaccines.

[22]  C. von Kalle,et al.  Safety, reactogenicity, and immunogenicity of homologous and heterologous prime-boost immunisation with ChAdOx1 nCoV-19 and BNT162b2: a prospective cohort study , 2021, The Lancet Respiratory Medicine.

[23]  B. Mizrahi,et al.  Correlation of SARS-CoV-2-breakthrough infections to time-from-vaccine , 2021, Nature Communications.

[24]  R. Myers,et al.  Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant , 2021, The New England journal of medicine.

[25]  A. Marchant,et al.  Immunological mechanisms of vaccine-induced protection against COVID-19 in humans , 2021, Nature Reviews Immunology.

[26]  A. Hayward,et al.  Spike-antibody waning after second dose of BNT162b2 or ChAdOx1 , 2021, The Lancet.

[27]  P. Olliaro.  An integrated understanding of long-term sequelae after acute COVID-19 , 2021, The Lancet Respiratory Medicine.

[28]  Khalid J. Alzahrani,et al.  Long-COVID and Post-COVID Health Complications: An Up-to-Date Review on Clinical Conditions and Their Possible Molecular Mechanisms , 2021, Viruses.

[29]  Yi Jiang,et al.  Efficacy and safety of COVID-19 vaccines: a systematic review. , 2021, Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics.

[30]  T. Piccoli,et al.  COVID-19 and Alzheimer’s Disease , 2021, Brain sciences.

[31]  Nguyen H. Tran,et al.  Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses , 2020, Nature Medicine.

[32]  K. Kim,et al.  What Is COVID-19? , 2020, Frontiers for Young Minds.

[33]  G. Alter,et al.  Sex differences in vaccine-induced humoral immunity , 2018, Seminars in Immunopathology.

[34]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[35]  S. Oertelt-Prigione.  The influence of sex and gender on the immune response. , 2012, Autoimmunity reviews.

[36]  W. Gradishar.  To Boost or Not to Boost , 2009 .

[37]  Wolzt,et al.  World Medical Association Declaration of Helsinki , 2000, International Journal of Pharmaceutical Medicine.

[38]  H. Steward.  Responses , 1991, Problems and Perspectives of Conventional Disarmament in Europe.

[39]  S. Klein,et al.  Sex-based differences in immune function and responses to vaccination. , 2015, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[40]  M. Fathalla,et al.  World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. , 2013, JAMA.

[41]  V. Preedy,et al.  Prospective Cohort Study , 2010 .

[42]  I. Hallström,et al.  AN OBSERVATIONAL STUDY , 2006 .